A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients

Abstract

Further development of such clinical augmentation tools that systematically combine patient-derived molecular data, real-world evidence from electronic health records and expert curated knowledgebases on biomarkers with computational tools for ranking best treatments can support care pathways at point of care.